Style | Citing Format |
---|---|
MLA | Adeli OA, et al.. "Effects and Mechanisms of Fisetin Against Ischemia-Reperfusion Injuries: A Systematic Review." Current Pharmaceutical Biotechnology, vol. 25, no. 16, 2024, pp. 2138-2153. |
APA | Adeli OA, Heidarisoureshjani S, Rostamian S, Azadegandehkordi Z, Khaghani A (2024). Effects and Mechanisms of Fisetin Against Ischemia-Reperfusion Injuries: A Systematic Review. Current Pharmaceutical Biotechnology, 25(16), 2138-2153. |
Chicago | Adeli OA, Heidarisoureshjani S, Rostamian S, Azadegandehkordi Z, Khaghani A. "Effects and Mechanisms of Fisetin Against Ischemia-Reperfusion Injuries: A Systematic Review." Current Pharmaceutical Biotechnology 25, no. 16 (2024): 2138-2153. |
Harvard | Adeli OA et al. (2024) 'Effects and Mechanisms of Fisetin Against Ischemia-Reperfusion Injuries: A Systematic Review', Current Pharmaceutical Biotechnology, 25(16), pp. 2138-2153. |
Vancouver | Adeli OA, Heidarisoureshjani S, Rostamian S, Azadegandehkordi Z, Khaghani A. Effects and Mechanisms of Fisetin Against Ischemia-Reperfusion Injuries: A Systematic Review. Current Pharmaceutical Biotechnology. 2024;25(16):2138-2153. |
BibTex | @article{ author = {Adeli OA and Heidarisoureshjani S and Rostamian S and Azadegandehkordi Z and Khaghani A}, title = {Effects and Mechanisms of Fisetin Against Ischemia-Reperfusion Injuries: A Systematic Review}, journal = {Current Pharmaceutical Biotechnology}, volume = {25}, number = {16}, pages = {2138-2153}, year = {2024} } |
RIS | TY - JOUR AU - Adeli OA AU - Heidarisoureshjani S AU - Rostamian S AU - Azadegandehkordi Z AU - Khaghani A TI - Effects and Mechanisms of Fisetin Against Ischemia-Reperfusion Injuries: A Systematic Review JO - Current Pharmaceutical Biotechnology VL - 25 IS - 16 SP - 2138 EP - 2153 PY - 2024 ER - |